Missouri Attorney General Sends Cease-and-Desist Letter to Drug Manufacturer

Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts

A Lilly spokesman said that the data requirement is "necessary to root out the rampant fraud, waste, and abuse that plague the 340B program."

Missouri AG hits drug manufacturer Eli Lilly with cease-and-desist order

Missouri's Attorney General issued a cease-and-desist letter to Eli Lilly Monday over the company's drug pricing.

Missouri Attorney General sends cease-and-desist letter to drug manufacturer

Missouri Attorney General issued a cease-and-desist to a company unlawfully requiring "extensive" data for medication discounts.

Missouri AG orders pharmaceutical company to stop unlawful prescription pricing conditions

Missouri Attorney General Catherine Hanaway is warning a major pharmaceutical company that it can no longer bully the state’s hospitals.

AG sends cease-and-desist letter to pharmaceutical company after pricing spat with MU Health Care

COLUMBIA, Mo. (KMIZ) Missouri Attorney General Catherine Hanaway announced on Monday that her office sent a cease-and-desist letter to a pharmaceutical company. A press release from Hanaway’s office claims Eli Lilly and Company cut off MU Health Care from 340B program pricing for refusing to comply with a policy change by the company “requiring 340B

Mo. Attorney General sends prescription manufacturer Eli Lilly cease-and-desist over drug price policy

The Entire Business World on a Single Page with the Web's Most Comprehensive One-Stop Finance News Hub.